Skip to main content
Annals of African Medicine logoLink to Annals of African Medicine
. 2026 Sep 2;25(6):1484–1490. doi: 10.4103/aam.aam_680_26

Clinico-Hematological Evaluation of Bicytopenia in Adults: A Hospital-based Observational Study

Vidya Kuchanur 1, Appu Patil 1,✉, Shivani S Rao 1
PMCID: PMC13645264  PMID: 42684007

Abstract

Background:

Bicytopenia is defined as a reduction in any two of the three major blood cell lineages and may result from a wide spectrum of infectious, nutritional, hematological, and systemic disorders. Early identification of the underlying etiology is essential for appropriate management.

Aims:

To study the etiological spectrum, hematological profile, clinical presentation, and patterns of bicytopenia among patients attending a tertiary care Center.

Materials and Methods:

The study analyzed the clinical and hematological profile of 110 patients with bicytopenia. Patients were categorized based on age, gender, hematological parameters, etiologies, symptoms, and type of bicytopenia. Statistical analysis was performed using the Chi-square test.

Results:

Patients in the study had a mean age of 41.5 ± 15.42 years with female predominance (54.5%). Viral fever, including dengue, was the leading cause (23.6%), subsequently nutritional deficiency (13.6%) and sepsis (11.8%). Leukopenia with thrombocytopenia was the most common type of bicytopenia (37.3%). Fever was the predominant presenting symptom (48.2%). The type of bicytopenia showed a significant association with of underlying etiology (P < 0.0001).

Conclusion:

Bicytopenia is associated with diverse etiologies ranging from transient infections to serious hematological disorders. Infectious diseases and nutritional deficiencies constituted the major causes in the present study. Recognition of hematological patterns along with systematic clinical evaluation can aid in early diagnosis and timely management.

Keywords: Bicytopenia, hematological disorders, nutritional deficiency, sepsis, viral fever

INTRODUCTION

Bicytopenia is a hematological abnormality characterized by reduction in any two of the three major blood cell lines – erythrocytes, leukocytes, and platelets. Alterations in blood cell counts can serve as important indicators of underlying diseases and help in assessing an individual’s health status.[1] Although pancytopenia has been extensively studied, bicytopenia remains relatively less explored despite its significant clinical importance. The etiological spectrum of bicytopenia varies widely and includes infections, nutritional deficiencies, bone marrow failure syndromes, and hematological malignancies.[2] In tropical countries like India, infectious diseases such as dengue, malaria, sepsis, and tuberculosis contribute significantly to bicytopenia, along with Vitamin B12 and folate deficiencies.[3]

Patients with bicytopenia may present with varied clinical manifestations including fever, pallor, weakness, bleeding tendencies, and recurrent infections. Since the underlying causes and management differ according to the type of cytopenia, early identification is essential for appropriate diagnosis and treatment.[3] Due to its wide differential diagnosis and varied clinical presentation, bicytopenia poses a diagnostic challenge to clinicians.

Only a limited number of studies in the literature have evaluated the etiological spectrum and clinicopathological profile of bicytopenia separately in adults, particularly in this region. To address this gap, the present study was conducted to evaluate the clinico-hematological profile and etiological spectrum of bicytopenia in adults and to correlate clinical features with hematological findings and assess the clinical significance of different patterns of bicytopenia.

MATERIALS AND METHODS

Study design

This hospital-based descriptive observational study was conducted over 1 year (April 2025–March 2026) at a tertiary care center.

Sample size calculation

The expected caseload is 180 cases/year. Sample size was calculated for:

Estimation of proportions with a 10% margin of error and a 95% confidence interval.

Formula:

n₀ = (Z2 × p × (1 − p))/d2

Z = 1.96 for 95% confidence

P = 0.5 (conservative estimate for maximum sample size)

d = 0.10 (10% margin of error)

Initial sample size (Infinite population)

n₀ = (1.962 × 0.5 × 0.5)/0.102

= (3.8416 × 0.25)/0.01

=96.04 ≈ 97

Finite population correction (N = 180)

n = n₀/[1+ (n₀−1)/N]

=96.04/[1+ (95.04/180)]

=96.04/1.528

=62.86 ≈ 63.

The required sample size for estimating proportions with 95% confidence and 10% precision was 63 patients. Although the calculated minimum sample size was 63, the study included 110 patients, as all consecutive eligible patients encountered during the 1-year study period were enrolled using consecutive sampling.

Study population

The present study included 110 patients, as all eligible cases presenting during the 1-year study period. Research was conducted in accordance with the ethical principles outlined in the Declaration of Helsinki (1964). Approval for the study was granted by the Ethics Committee KLE JGMMMC, Hubli (JGMMMCICIEC/166/2026).

Bicytopenia was defined as reduction in any two of the following peripheral blood parameters: Hemoglobin below the reference range, total leukocyte count <4000/µL, and platelet count <150,000/µL. Patients with known hematological malignancies, recent chemotherapy/radiotherapy, major blood loss, pregnancy, and incomplete clinical data were excluded.

Detailed clinical history, physical examination, complete blood count using an automated hematology analyzer, and peripheral blood smear examination were performed in all cases. Additional investigations including serum vitamin B12, folate levels, liver and renal function tests, viral markers, dengue, and malaria tests were carried out when clinically indicated. Bone marrow aspiration and/or biopsy was performed in selected cases where bicytopenia remained unexplained or marrow pathology was suspected.

Patients were classified into anemia with leukopenia, anemia with thrombocytopenia, and leukopenia with thrombocytopenia groups. Data were analyzed using MedCalc Statistical Software version 14.0.1 (MedCalc Software Ltd, Ostend, Belgium). Descriptive statistics were expressed as frequencies, percentages, mean, and standard deviation. Chi-square test was used for analysis, and P < 0.05 was considered statistically significant.

RESULTS

Age-wise distribution of cases

A total of 110 cases were included in the study. The mean age of the patients was 41.5 years with a standard deviation of 15.42 years. The median age was 41 years, and the age ranged from 17 to 70 years.

The majority of cases were observed in the 51–60 years age group comprising 24 patients (21.8%), followed by the 21–30 years and 31–40 years age groups with 23 patients each (20.9%). The least number of cases were seen in the 18–20 years age group accounting for 9 patients (8.2%) [Table 1].

Table 1.

Age-wise distribution of cases

Age groups Number of patients (%)
18–20 9 (8.2)
21–30 23 (20.9)
31–40 23 (20.9)
41–50 17 (15.5)
51–60 24 (21.8)
61–70 14 (12.7)
Total 110 (100)

Gender distribution

Out of the total 110 cases included in the study, females constituted a slightly higher proportion with 60 patients (54.5%), while males accounted for 50 patients (45.5%) [Table 2].

Table 2.

Gender distribution among study participants

Gender Number of patients (%)
Male 50 (45.5)
Female 60 (54.5)
Total 110 (100)

Hematological parameters

Hemoglobin distribution

Among the 110 cases studied, hemoglobin level ≥10 g/dL were observed in the majority of patients, accounting for 41 cases (37.3%). Hemoglobin levels between 6 and 8 g/dL were noted in 31 cases (28.2%), while severe anemia with hemoglobin <6 g/dL was seen in 23 cases (20.9%). Hemoglobin levels between 8 and 10 g/dL were observed in 15 cases (13.6%) [Table 3].

Table 3.

Hemoglobin distribution among study participants

Hemoglobin Number of cases (%)
<6 23 (20.9)
6–8 31 (28.2)
8–10 15 (13.6)
≥10 41 (37.3)
Total 110 (100)

White blood cell count distribution

Leukocyte counts between 1000 and <4000 cells/mm3 were observed in the majority of patients, comprising 76 cases (69.1%). Normal leukocyte counts ranging from 4000 to <11,000 cells/mm3 were seen in 29 cases (26.4%), while elevated leukocyte counts ≥11,000 cells/mm3 were noted in only 5 cases (4.5%) [Table 4].

Table 4.

White blood cell count distribution among study participants

Leucocyte count Number of cases (%)
≥1000–<4000 76 (69.1)
≥4000–<11,000 29 (26.4)
≥11,000 5 (4.5)
Total 110 (100)

Platelet count distribution

Platelet counts >100,000/mm3 were observed in the majority of cases, accounting for 50 patients (45.5%). Platelet counts between 50,000 and 100,000/mm3 were seen in 33 cases (30.0%), while counts between 20,000 and 50,000/mm3 were noted in 23 cases (20.9%). Severe thrombocytopenia with platelet counts <20,000/mm3 was observed in 4 cases (3.6%) [Table 5].

Table 5.

Platelet count distribution among study participant

Platelet count Number of cases (%)
<20,000 4 (3.6)
20,000–50,000 23 (20.9)
50,000–100,000 33 (30.0)
>100,000 50 (45.5)
Total 110 (100)

Among the 110 cases studied, viral fever including dengue was the most common etiology, accounting for 26 cases (23.6%). Nutritional deficiency was the second most common cause observed in 15 cases (13.6%), followed by sepsis in 13 cases (11.8%). Myelodysplastic syndrome (MDS) accounted for 8 cases (7.3%), while malaria was seen in 7 cases (6.4%). Chronic liver disease (CLD) contributed to 6 cases (5.5%), and aplastic anemia was noted in 5 cases (4.5%).

Acute myeloid leukemia (AML) was identified in 4 cases (3.6%). Chronic leukemias, hypersplenism, and retroviral disease accounted for 3 cases each (2.7%). Antiepileptic drugs, anti-tubercular therapy drugs, immune thrombocytopenic purpura (ITP), pneumonia, and tuberculosis were responsible for 2 cases each (1.8%). Single cases (0.9%) were attributed to antiretroviral therapy drugs, chronic obstructive pulmonary disease, enteric fever, pancreatitis, systemic lupus erythematosus, urinary tract infection, and pyrexia of unknown origin [Table 6].

Table 6.

Etiological spectrum of bicytopenia

Etiology Number of cases (%)
AML 4 (3.6)
Antiepileptic drugs 2 (1.8)
Aplastic anemia 5 (4.5)
ART drugs 1 (0.9)
ATT drugs 2 (1.8)
CLD 6 (5.5)
Chronic leukemia (CML/CLL) 3 (2.7)
COPD 1 (0.9)
Viral fever (including dengue) 26 (23.6)
Enteric fever 1 (0.9)
Hypersplenism 3 (2.7)
ITP 2 (1.8)
Malaria 7 (6.4)
MDS 8 (7.3)
Nutritional deficiency 15 (13.6)
Pancreatitis 1 (0.9)
Pneumonia 2 (1.8)
Retroviral disease 3 (2.7)
Sepsis 13 (11.8)
SLE 1 (0.9)
TB 2 (1.8)
UTI 1 (0.9)
PUO 1 (0.9)
Total 110 (100)

AML=Acute myeloid leukemia, PUO=Pyrexia of unknown origin, SLE=Systemic lupus erythematosus, UTI=Urinary tract infection, TB=Tuberculosis, MDS=Myelodysplastic syndrome, ITP=Immune thrombocytopenic purpura, CML=Chronic myeloid leukemia, CLL=Chronic lymphocytic leukemia, ART=Antiretroviral therapy, COPD=Chronic obstructive pulmonary disease, CLD=Chronic liver disease, ATT=Anti-tuberculosis therapy

Clinical presentation/symptoms

Fever was the most common presenting symptom observed in 53 instances (48.2%), followed by pallor in 21 cases (19.1%) and petechial rashes in 15 cases (13.6%). Weakness was reported in 13 cases (11.8%), while myalgia was present in 11 cases (10%). Lymphadenopathy was noted in 8 cases (7.3%). Tingling and numbness of hands and feet, as well as jaundice, were each observed in 7 cases (6.4%). Splenomegaly and headache were seen in 5 cases each (4.5%). Vomiting, gum bleeding, hepatomegaly, and rashes accounted for 2 cases each (1.8%), while fatigue was noted in 1 case (0.9%). As multiple symptoms were present in several patients, the total number of symptoms exceeded the total number of cases [Table 7].

Table 7.

Clinical presentation/symptoms among study participants

Symptoms Number of cases (%)
Fever 53 (48.2)
Pallor 21 (19.1)
Petechial rashes 15 (13.6)
Weakness 13 (11.8)
Myalgia 11 (10)
Lymphadenopathy 8 (7.3)
Tingling + numbness of hands and feet 7 (6.4)
Jaundice 7 (6.4)
Splenomegaly 5 (4.5)
Headache 5 (4.5)
Vomiting 2 (1.8)
Gum bleeding 2 (1.8)
Hepatomegaly 2 (1.8)
Rashes 2 (1.8)
Fatigue 1 (0.9)
Total 154

Bicytopenia pattern

Among the 110 cases studied, leukopenia with thrombocytopenia was the most common type of bicytopenia observed in 41 cases (37.3%). Anemia with leukopenia was seen in 36 cases (32.7%), while anemia with thrombocytopenia was noted in 33 cases (30.0%) [Table 8].

Table 8.

Bicytopenia pattern among study participants

Bicytopenia Number of cases (%)
Anemia + leukopenia 36 (32.7)
Anemia + thrombocytopenia 33 (30.0)
Leukopenia + thrombocytopenia 41 (37.3)
Total 110 (100)

Association of type of bicytopenia with etiologies

Anemia with leukopenia was predominantly associated with nutritional deficiency (12 cases), MDS (8 cases), and aplastic anemia (5 cases). Anemia with thrombocytopenia was commonly observed in CLD (6 cases), malaria (7 cases), viral fever including dengue (8 cases), and AML (3 cases).

Leukopenia with thrombocytopenia was strongly associated with sepsis (13 cases) and viral fever including dengue (18 cases). Hypersplenism and retroviral disease also showed a predominance of leukopenia with thrombocytopenia.

Statistical analysis using the Chi-square test demonstrated a significant association between the type of bicytopenia and underlying etiology (P < 0.0001) [Table 9].

Table 9.

Association of type of bicytopenia with etiologies

Etiology Anemia + leukopenia Anemia + thrombocytopenia Leukopenia + thrombocytopenia Total
AML 0 3 1 4
Antiepileptic drugs 1 1 0 2
Aplastic anemia 5 0 0 5
ART drugs 1 0 0 1
ATT drugs 2 0 0 2
CLD 0 6 0 6
Chronic leukemia (CML/CLL) 0 3 0 3
COPD 1 0 0 1
Viral fever (including dengue) 0 8 18 26
Enteric fever 1 0 0 1
Hypersplenism 0 0 3 3
ITP 0 2 0 2
Malaria 0 7 0 7
MDS 8 0 0 8
Nutritional deficiency 12 2 1 15
Pancreatitis 0 1 0 1
Pneumonia 1 0 1 2
Retroviral disease 1 0 2 3
Sepsis 0 0 13 13
SLE 0 0 1 1
TB 2 0 0 2
UTI 1 0 0 1
PUO 0 0 1 1
Total 36 33 41 110
Chi-square test P=<0.0001 Significant

AML=Acute myeloid leukemia, PUO=Pyrexia of unknown origin, SLE=Systemic lupus erythematosus, UTI=Urinary tract infection, TB=Tuberculosis, MDS=Myelodysplastic syndrome, ITP=Immune thrombocytopenic purpura, CML=Chronic myeloid leukemia, CLL=Chronic lymphocytic leukemia, ART=Antiretroviral therapy, COPD=Chronic obstructive pulmonary disease, CLD=Chronic liver disease, ATT=Anti-tuberculosis therapy

Common causes of bicytopenia - age-wise distribution

Viral fever was the most common cause of bicytopenia in the younger and middle-aged groups, particularly among patients aged 11–20 years, 21–30 years, 41–50 years, and 51–60 years. Nutritional deficiency emerged as a major cause in the 31–40 years and 61–70 years age groups.

Sepsis was identified as the second-most common cause in several age categories, especially among patients aged 21–30 years and 31–40 years. CLD was the second most common cause in the 51–60 years age group [Table 10].

Table 10.

Common causes of bicytopenia - age-wise distribution

Age groups Most common cause Second most common cause
18–20 Viral fever (3 cases) -
21–30 Viral fever (6 cases) Sepsis (4 cases)
31–40 Nutritional deficiency (4 cases) and viral fever (4 cases) Sepsis (3 cases)
41–50 Viral fever (6 cases) Nutritional deficiency (megaloblastic, 2 cases)
51–60 Viral fever (5 cases) Chronic liver disease (3 cases)
61–70 Nutritional deficiency (megaloblastic, 3 cases) Sepsis (2 cases) and viral fever (2 cases)

Bone marrow studies were carried out in 22 of the 110 patients where clinically indicated. Megaloblastic anemia was followed by acute leukemia of myeloid origin among the common marrow findings and ITP. Other observed findings included, other marrow findings included normoblastic normocellular marrow, micronormoblastic marrow, hypocellular marrow, and hypoplastic marrow.

DISCUSSION

Bicytopenia is a commonly encountered hematological abnormality in clinical practice and may occur due to a wide range of underlying conditions, varying from transient infections to serious bone marrow disorders and hematological malignancies. Bicytopenia has been recognized in various clinical studies and therapeutic trials; however, dedicated research exploring its clinical and etiological profile in adults remains limited. This study was carried out to assess the clinical profile, hematological findings, and etiological spectrum of bicytopenia in adult patients attending a tertiary care center.

The mean age of patients in this study was 41.5 years, with most patients belonging to the 21–30, 31–40, and 51–60 years age groups. A slight female predominance was observed. Similar results have been observed in other studies,[2,3] where bicytopenia was more commonly seen among adults and females, possibly due to the higher prevalence of nutritional deficiencies and infectious diseases.

The majority of patients had hemoglobin levels ≥10 g/dL (37.3%), followed by 6–8 g/dL (28.2%), whereas only 20.9% of cases had hemoglobin levels <6 g/dL. This differs from the study conducted by Singh et al., where most cytopenia cases had hemoglobin values <8 g/dL and a higher proportion showed severe anemia with hemoglobin <6 g/dL.[3] Regarding leukocyte counts, the present study demonstrated leukopenia (1000–4000/µL) in 69.1% of cases, which is comparable to the Singh et al.’s study where 61.1% of cytopenia cases had leukocyte counts within the same range.[3] In terms of platelet counts, most patients in this study had platelet counts >100,000/µL (45.5%), while 30% had counts between 50,000 and 100,000/µL and only 3.6% had severe thrombocytopenia (<20,000/µL). In contrast, the Singh et al. study reported a higher proportion of patients with platelet counts between 20,000 and 100,000/µL and a comparatively greater frequency of severe thrombocytopenia.[3] These differences may be due to variations in study population, underlying etiologies, and severity of hematological involvement.

Naseem et al. and Singh et al. reported fever and pallor as the most common clinical features with bicytopenia, followed by petechial rash, bleeding manifestations, and bone pain. Hepatomegaly and splenomegaly were the predominant physical findings in their study.[2,3] Similar observations were noted in the present study, where fever was the most frequent presenting complaint in this study followed by pallor and petechial rash. In the present study, lymphadenopathy, splenomegaly, and hepatomegaly were observed in a subset of patients, particularly among those with hematological malignancies. Comparable findings have been observed in earlier studies, where lymphadenopathy, splenomegaly, and hepatomegaly were commonly seen in patients with acute leukemias.[4]

According to Naseem et al., the causes of bicytopenia and pancytopenia are diverse and range from transient viral marrow suppression to serious hematological disorders such as leukemia.[2] In the study by Singh et al., megaloblastic marrow was the most common etiology of bicytopenia, followed by acute leukemia, hypoplastic marrow, and ITP.[3] In contrast, the present study demonstrated that viral fever, including dengue, emerged as the leading cause of bicytopenia, followed by nutritional deficiency and sepsis. However, nutritional deficiency remained one of the major etiological factors in both studies. The variation in etiological patterns may be attributed to differences in age groups studied, geographic distribution, prevalence of infectious diseases, and referral patterns at tertiary care centers.

Most studies in the literature have mainly focused on pancytopenia, while only a few have evaluated bicytopenia separately. Aplastic anemia has been reported as one of the most common causes of pancytopenia in several studies worldwide.[2,6,7,8] However, Bhatnagar et al. reported megaloblastic anemia as the most common etiological factor,[9,10] highlighting the variation in hematological disorders across different populations and geographic regions.

In this study, leukopenia with thrombocytopenia was the most common type of bicytopenia observed in 37.3% of cases, subsequently by anemia with leukopenia (32.7%) and anemia with thrombocytopenia (30.0%). This differs from the study conducted by Singh et al., where anemia with thrombocytopenia was the predominant pattern of bicytopenia and leukopenia with thrombocytopenia was the least common type.[3] The higher frequency of leukopenia with thrombocytopenia, this variation may be explained by the predominance of infectious etiologies such as viral fever, dengue, and sepsis, which commonly affect leukocyte and platelet counts simultaneously.

Overall, the study shows that bicytopenia is not a disease by itself but an important hematological manifestation of several underlying conditions. Careful clinical assessment supported by hematological investigations and bone marrow examination, whenever necessary, is essential for accurate diagnosis and timely management.

Limitations of the study

The present study was carried out at a tertiary care Center with a relatively small sample size, limiting generalizability. Bone marrow examination and advanced investigations were not performed uniformly in all patients, and nutritional parameters were unavailable in some cases. Additionally, follow-up data and seasonal variations in infectious diseases may have influenced the study findings.

CONCLUSION

Bicytopenia is an important hematological abnormality associated with a wide range of infectious, nutritional, and hematological disorders. In the present study, viral fever, including dengue, was the most common etiology, with leukopenia and thrombocytopenia being the predominant pattern. Bone marrow examination plays a valuable role in selected cases for differentiating benign from malignant causes. The study emphasizes the importance of early clinical evaluation and hematological investigations in identifying the underlying cause, enabling timely diagnosis and appropriate management.

Clinical implications

  1. Early etiological identification - Recognition of bicytopenia patterns can help clinicians rapidly identify common underlying causes such as infections, nutritional deficiencies, marrow disorders, and hematological malignancies, enabling timely management.

  2. Guidance for diagnostic workup - Specific combinations of cytopenias may aid in prioritizing investigations such as peripheral smear examination, infectious disease screening, nutritional assessment, and bone marrow evaluation.

  3. Recognition of treatable causes - A significant proportion of bicytopenia cases in the present study were due to reversible conditions such as viral infections, sepsis, malaria, and nutritional deficiency, emphasizing the importance of early diagnosis and appropriate treatment.

  4. Future directions - Larger multicentric studies with long-term follow-up are needed to better define the etiological spectrum, prognostic significance, and standardized diagnostic approach for bicytopenia.

Conflicts of interest

There are no conflicts of interest.

Funding Statement

Nil.

REFERENCES

  • 1.Bates I, Bain B. Approach to diagnosis and classification of blood diseases. In: Lewis S, Bain B, Bates I, editors. Dacie and Lewis Practical Haematology. 11th ed. Vol. 549. Philadelphia: Churchill Livingstone; 2012. p. 62. [Google Scholar]
  • 2.Naseem S, Varma N, Das R, Ahluwalia J, Sachdeva MU, Marwaha RK. Pediatric patients with bicytopenia/pancytopenia: Review of etiologies and clinico-hematological profile at a tertiary center. Indian J Pathol Microbiol. 2011;54:75–80. doi: 10.4103/0377-4929.77329. [DOI] [PubMed] [Google Scholar]
  • 3.Singh A, Hungund B, Kumar L, Pattanshetti M. Clinico-hematological profile of patients with bicytopenia. Pathology. 2018;50:540–8. doi: 10.1016/j.pathol.2018.03.008. [DOI] [PubMed] [Google Scholar]
  • 4.Khodke K, Marwah S, Buxi G, Yadav RB, Chaturvedi NK. Bone marrow examination in cases of Pancytopenia. JIACM. 2001;2:55–59. [Google Scholar]
  • 5.Gayathri BN, Rao KS. Pancytopenia: A clinico-hematological study. J Lab Physicians. 2011;3:15–20. doi: 10.4103/0974-2727.78555. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Memon S, Shaikh S, Nizamani MA. Etiological spectrum of pancytopenia based on bone marrow examination in children. J Coll Physicians Surg Pak. 2008;18:163–7. [PubMed] [Google Scholar]
  • 7.Gupta V, Tripathi S, Tilak V, Bhatia BD. A study of clinico-haematological profiles of pancytopenia in children. Trop Doct. 2008;38:241–3. doi: 10.1258/td.2008.070422. [DOI] [PubMed] [Google Scholar]
  • 8.Jha A, Sayami G, Adhikari RC, Panta AD, Jha R. Bone marrow examination in cases of pancytopenia. J Nepal Med Assoc. 2008;47:12–7. [PubMed] [Google Scholar]
  • 9.Bhatnagar SK, Chandra J, Narayan S, Sharma S, Singh V, Dutta AK. Pancytopenia in children: Etiological profile. J Trop Pediatr. 2005;51:236–9. doi: 10.1093/tropej/fmi010. [DOI] [PubMed] [Google Scholar]
  • 10.Javalgi AP, Dombale VD. Clinico-hematological analysis of pancytopenia: A bone marrow study. Natl J Lab Med. 2013;2:12–7. [Google Scholar]

Articles from Annals of African Medicine are provided here courtesy of Wolters Kluwer -- Medknow Publications

RESOURCES